ISO 10993-1 Biological Evaluation of Medical Devices
Designed for medical device engineers, toxicologists, regulatory professionals, and quality staff who need to apply ISO 10993-1 within a risk management process. By the end, learners will be able to plan biological evaluations, select and justify evidence and testing across the ISO 10993 series, assess biological risks, and prepare a defensible Biological Evaluation Report.
5,000.00 LE
5000.0
EGP
5,000.00 LE
| Responsible | Rehaf Foula |
|---|---|
| Last Update | 10/18/2026 |
| Members | 1 |
Health
-
1. Evaluation Foundations1Lessons ·
-
1.1 WelcomeNew
-
-
2. Planning the Evaluation2Lessons ·
-
2.1 Purpose of the Biological Evaluation PlanNew
-
2.2 Building a Device Evidence StrategyNew
-
-
3. Contact Categorization4Lessons ·
-
3.1 Defining Body ContactNew
-
3.2 Classifying Contact DurationNew
-
3.3 Accounting for Exposure ChangesNew
-
3.4 Applying Contact CategoriesNew
-
-
4. Biological Endpoints3Lessons ·
-
4.1 Mapping Relevant EndpointsNew
-
4.2 Endpoint Evidence and HazardsNew
-
4.3 When Endpoints Need TestingNew
-
-
5. Chemical Characterization2Lessons ·
-
5.1 Role of Chemical CharacterizationNew
-
5.2 Defining Materials and ConstituentsNew
-